Weiss Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31M Buy
+38,094
New +$2.22M 0.04% 250
2025
Q4
Sell
-73,479
Closed -$3.31M 612
2025
Q3
$3.31M Buy
+73,479
New +$3.43M 0.04% 198
2025
Q2
Sell
-152,646
Closed -$9.31M 425
2025
Q1
$9.31M Buy
+152,646
New +$8.9M 0.19% 72
2021
Q3
Sell
-83,608
Closed -$5.59M 509
2021
Q2
$5.59M Buy
+83,608
New +$5.45M 0.14% 195
2021
Q1
Sell
-5
Closed 503
2020
Q4
$0 Buy
+5
New +$307 ﹤0.01% 308
2020
Q1
Sell
-3,870
Closed -$248K 221
2019
Q4
$248K Buy
+3,870
New +$222K 0.02% 197

Other funds holding BMY

Weiss Asset Management's BMY Position: Q1 2026 in Review

Weiss Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 38,094 shares worth $2.31M. The stake represents 0.04% of the portfolio and ranks #250 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in BMY as recently as Q3 2025.

Weiss Asset Management first reported a position in BMY in Q4 2019 and has held it in 6 quarters since. The position peaked at $9.31M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Weiss Asset Management held 38,094 shares of Bristol-Myers Squibb worth $2.31M as of Q1 2026.
  • Bristol-Myers Squibb was a new Weiss Asset Management position in Q1 2026.
  • Bristol-Myers Squibb made up 0.04% of Weiss Asset Management's portfolio in Q1 2026, its #250 holding.
  • Weiss Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 6 quarters since.
  • Weiss Asset Management's Bristol-Myers Squibb position peaked at $9.31M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Weiss Asset Management's 13F filing for Q1 2026, filed 15 May 2026.